Drugs / Fibrin Sealant VH S/D
last change Dec 2002 re-read 3 minutes ago

Fibrin Sealant VH S/D

Developed for
lymphedema
Investigated by
Baxter Healthcare Corporation

Trials 1

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00161980 Jun 2001 → Dec 2002 breast cancer, lymphedema Baxter Healthcare Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fibrin Sealant VH S/D ClinicalTrials.gov intervention name — accepted as the source's own label NCT00161980 ↗